journal article·2019-12-04Open access

Emodin weakens liver inflammatory injury triggered by lipopolysaccharide through elevating microRNA-145 in vitro and in vivo

RuiJin Xie, Mei Liu, ShuJie Li

Abstract

Hepatitis is a severe liver disease with worldwide distribution. This study explored the anti-inflammatory influence of Emodin on LPS-triggered liver injury in vitro and in vivo. In vitro, we discovered that LPS treatment triggered L-02 cell and primary hepatocyte inflammatory injury. Emodin weakened the LPS-triggered cell inflammatory injury and NF-κB pathway activation. Emodin alleviated LPS-stimulated decrease of miR-145 expression. Moreover, miR-145 participated in the regulation of pro-inflammatory factors expression and negatively regulated IRAK1. Besides, IRAK1 exert regulatory roles in the activation of NF-κB pathway. In vivo, we found that Emodin pre-treatment weakened the LPS-triggered increases of pro-inflammatory factors expression, up-regulations of AST and ALT level, liver cell apoptosis, reduction of miR-145 and enhancement of IRAK1. Our research verified that Emodin weakened LPS-triggered liver cell inflammatory injury in vitro and in vivo might be achieved by elevating miR-145, decreasing IRAK1 and then suppressing NF-κB pathway.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Phytochemistry and biological activity of medicinal plants · Pharmacological Effects of Natural Compounds · Ginger and Zingiberaceae research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Gastroenterology, Jining No.1 People’s Hospital

Department of Rheumatology and Immunology, Jining No.1 People’s Hospital

References (42)

Show source-provided references
1. 10.1159/00044446710.1159/000444467 ↗
2. 10.1016/j.bbrc.2009.06.02410.1016/j.bbrc.2009.06.024 ↗
3. 10.1016/j.antiviral.2015.10.01410.1016/j.antiviral.2015.10.014 ↗
4. 10.5009/gnl1535210.5009/gnl15352 ↗
5. 10.1016/S0168-8278(12)60005-110.1016/S0168-8278(12)60005-1 ↗
6. 10.3126/kumj.v11i3.1251110.3126/kumj.v11i3.12511 ↗
7. 10.1016/j.ijsu.2016.10.03310.1016/j.ijsu.2016.10.033 ↗
8. 10.3892/mmr.2015.457410.3892/mmr.2015.4574 ↗
9. 10.3390/ijms13111391110.3390/ijms131113911 ↗
10. 10.1248/bpb.34.143210.1248/bpb.34.1432 ↗
11. 10.3390/ijms1302227610.3390/ijms13022276 ↗
12. 10.1016/j.fct.2012.10.06110.1016/j.fct.2012.10.061 ↗
13. 10.1016/j.enconman.2013.09.02010.1016/j.enconman.2013.09.020 ↗
14. 10.1016/j.bbrc.2015.07.10710.1016/j.bbrc.2015.07.107 ↗
15. 10.1186/1471-2407-14-72110.1186/1471-2407-14-721 ↗
16. 10.1159/00043852210.1159/000438522 ↗
17. 10.1016/S0300-483X(00)00290-010.1016/S0300-483X(00)00290-0 ↗
18. 10.1016/j.intimp.2015.03.02610.1016/j.intimp.2015.03.026 ↗
19. 10.1111/imm.1230510.1111/imm.12305 ↗
20. 10.1002/hep.2921510.1002/hep.29215 ↗
21. 10.1186/s13578-017-0173-310.1186/s13578-017-0173-3 ↗
22. 10.1016/j.foodchem.2014.06.02210.1016/j.foodchem.2014.06.022 ↗
23. 10.3390/molecules19111713010.3390/molecules191117130 ↗
24. 10.1007/978-1-60761-611-5_710.1007/978-1-60761-611-5_7 ↗
25. 10.1016/j.biopha.2017.05.12210.1016/j.biopha.2017.05.122 ↗
26. 10.1111/jcmm.1383110.1111/jcmm.13831 ↗
27. 10.1159/00037397110.1159/000373971 ↗
28. 10.1007/978-1-61779-860-3_510.1007/978-1-61779-860-3_5 ↗
29. 10.1007/978-3-319-28383-8_2310.1007/978-3-319-28383-8_23 ↗
30. 10.3389/fpls.2015.0079910.3389/fpls.2015.00799 ↗
31. 10.1002/bmc.432910.1002/bmc.4329 ↗
32. Kasprzak A, Seidel J, Spachacz R, et al. Intracellular expression of pro-inflammatory cytokines (IL-1alpha, TNF-alpha, and IL-6) in chronic hepatitis C. Roczniki Akademii Medycznej w Bialymstoku (1995). 2004;49:207–209.
33. 10.1016/j.gene.2008.07.01510.1016/j.gene.2008.07.015 ↗
34. 10.1093/abbs/gmt12810.1093/abbs/gmt128 ↗
35. 10.1146/annurev-biochem-060308-10310310.1146/annurev-biochem-060308-103103 ↗
36. 10.1371/journal.pone.005165510.1371/journal.pone.0051655 ↗
37. 10.1111/febs.1257410.1111/febs.12574 ↗
38. 10.1016/j.bcp.2013.05.00610.1016/j.bcp.2013.05.006 ↗
39. 10.1016/j.molimm.2006.03.02110.1016/j.molimm.2006.03.021 ↗
40. 10.1074/jbc.M109.05950110.1074/jbc.M109.059501 ↗
41. 10.1016/j.cellimm.2012.10.00110.1016/j.cellimm.2012.10.001 ↗
42. 10.1007/s10753-015-0153-x10.1007/s10753-015-0153-x ↗